Greg Gocal
Founder bei CALYXT, INC.
Vermögen: 288 252 $ am 31.03.2024
Profil
Greg Gocal is the founder of Cibus Corp.
which was founded in 2001.
He holds the title of Chief Scientific Officer & Executive VP at Cibus Corp.
Dr. Gocal is currently the Chief Scientific Officer at Cibus US LLC, Cibus, Inc., and Cibus Ltd.
Dr. Gocal has previously worked as a Principal at The Salk Institute for Biological Studies, Valigen NV, and CSIRO's ICT Sector Advisory Council.
Dr. Gocal has a doctorate degree from Australian National University and undergraduate and graduate degrees from the University of Calgary.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
CIBUS, INC. CLASS A
0,06% | 31.05.2023 | 12 834 ( 0,06% ) | 288 252 $ | 31.03.2024 |
Aktive Positionen von Greg Gocal
Unternehmen | Position | Beginn |
---|---|---|
CALYXT, INC. | Founder | 01.01.2001 |
CALYXTPAR | Chief Tech/Sci/R&D Officer | - |
Cibus US LLC
Cibus US LLC BiotechnologyHealth Technology Cibus Genetics LLC is a biotechnology company. It develops products in agriculture and specialty chemicals. The company was founded by Peter Beetham in 2001 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
Cibus Ltd.
Cibus Ltd. BiotechnologyHealth Technology Cibus Ltd. is a biotechnology company, which engages in the research and development of plant gene editing technology. It focuses on the commercialization of proprietary gene-editing technology, which refer to as the Rapid Trait Development System (RTDS). The RTDS enables to introduce customizable, specific, and predictable value-enhancing traits into plants and microorganisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Greg Gocal
Unternehmen | Position | Ende |
---|---|---|
CSIRO's ICT Sector Advisory Council | Corporate Officer/Principal | - |
The Salk Institute for Biological Studies | Corporate Officer/Principal | - |
Valigen NV
Valigen NV Miscellaneous Commercial ServicesCommercial Services Valigen NV offers genotyping and functional genomics. The company is headquartered in Newtown, PA. | Corporate Officer/Principal | - |
Ausbildung von Greg Gocal
Australian National University | Doctorate Degree |
University of Calgary | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
Cibus Corp.
Cibus Corp. BiotechnologyHealth Technology Cibus Corp. engages in the development of plant and microbial platforms. Its focuses in inputting traits and agronomic traits in canola, rice, soybean, corn, and wheat crops. The company was founded by Peter Beetham, Greg Gocal, Keith Walker, and Rory Riggs in 2001 and is headquartered in San Diego, CA. | Health Technology |
Valigen NV
Valigen NV Miscellaneous Commercial ServicesCommercial Services Valigen NV offers genotyping and functional genomics. The company is headquartered in Newtown, PA. | Commercial Services |
Cibus US LLC
Cibus US LLC BiotechnologyHealth Technology Cibus Genetics LLC is a biotechnology company. It develops products in agriculture and specialty chemicals. The company was founded by Peter Beetham in 2001 and is headquartered in San Diego, CA. | Health Technology |
CSIRO's ICT Sector Advisory Council | |
Cibus, Inc. | |
Cibus Ltd.
Cibus Ltd. BiotechnologyHealth Technology Cibus Ltd. is a biotechnology company, which engages in the research and development of plant gene editing technology. It focuses on the commercialization of proprietary gene-editing technology, which refer to as the Rapid Trait Development System (RTDS). The RTDS enables to introduce customizable, specific, and predictable value-enhancing traits into plants and microorganisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Health Technology |